Cardiovascular effects of intravenous colforsin in normal and acute respiratory acidosis canine models: A dose-response study
Authors:
Open Access
- 10 July 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (7) , e0213414
Abstract
In acidosis, catecholamines are attenuated, and higher doses are often required to improve cardiovascular function. Colforsin activates adenylate cyclase in cardiomyocytes without beta-adrenoceptor. Here, six beagles were administered colforsin or dobutamine four times during eucapnia (partial pressure of arterial carbon dioxide 35–40 mm Hg; normal) and hypercapnia (ibid 90–110 mm Hg; acidosis) conditions. The latter was induced by CO2 inhalation. Anesthesia was induced with propofol and maintained with isoflurane. Cardiovascular function was measured by thermodilution and a Swan-Ganz catheter at baseline and 60 min after 0.3 μg/kg/min (low), 0.6 μg/kg/min (middle), and 1.2 μg/kg/min (high) colforsin administration. The median pH was 7.38 [range 7.33–7.42] and 7.01 [range 6.96–7.08] at baseline in the Normal and Acidosis conditions, respectively. Endogenous adrenaline and noradrenaline levels at baseline were significantly (P < 0.05) higher in the Acidosis than in the Normal condition. Colforsin induced cardiovascular effects similar to those caused by dobutamine. Colforsin increased cardiac output in the Normal condition (baseline: 3.9 ± 0.2 L/kg/m2 [mean ± standard error], low: 5.2 ± 0.4 L/kg/min2, middle: 7.0 ± 0.4 L/kg/m2, high: 9.4 ± 0.2 L/kg/m2; P < 0.001) and Acidosis condition (baseline: 6.1 ± 0.3 L/kg/m2, low: 6.2 ± 0.2 L/kg/m2, middle: 7.2 ± 0.2 L/kg/m2, high: 8.3 ± 0.2 L/kg/m2; P < 0.001). Colforsin significantly increased heart rate and decreased systemic vascular resistance compared to values at baseline. Both drugs increased pulmonary artery pressure, but colforsin (high: 13.3 ± 0.6 mmHg in Normal and 20.1 ± 0.2 mmHg in Acidosis) may have lower clinical impact on the pulmonary artery than dobutamine (high: 19.7 ± 0.6 in Normal and 26.7 ± 0.5 in Acidosis). Interaction between both drugs and experimental conditions was observed in terms of cardiovascular function, which were similarly attenuated with colforsin and dobutamine under acute respiratory acidosis.Keywords
All Related Versions
This publication has 32 references indexed in Scilit:
- Mild metabolic acidosis impairs the β-adrenergic response in isolated human failing myocardiumCritical Care, 2012
- Sex differences and the effects of ovariectomy on the β-adrenergic contractile responseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Diagnostic Value of Echo-Doppler and Tissue Doppler Imaging in Dogs with Pulmonary Arterial HypertensionJournal of Veterinary Internal Medicine, 2007
- Doppler echocardiography–derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001–2005)Journal of the American Veterinary Medical Association, 2006
- Impact of dopamine or dobutamine infusions on cardiovascular variables after rapid blood loss and volume replacement during isoflurane-induced anesthesia in dogsAmerican Journal of Veterinary Research, 2006
- Comparison of the Renal and Pulmonary Hemodynamic Effects of Fenoldopam, Dobutamine, Dopamine and Norepinephrine in the Anesthetized DogPharmacology, 1988
- Review: The Pharmacology of DobutamineThe American Journal of the Medical Sciences, 1987
- Catecholamine-Induced Hyperglycemia in Dogs: Independence from Alterations in Pancreatic Hormone ReleaseHormone and Metabolic Research, 1980
- Comparative systemic and regional hemodynamic effects of dopamine and dobutamineAmerican Heart Journal, 1975
- The Effects of Changes in Pa CO 2 Cerebral Blood Volume, Blood Flow, and Vascular Mean Transit TimeStroke, 1974